My Parkinson's disease neurologist has just prescribed rytary, the new extended release version of levodopa that the FDA approved in January. But for nearly a month now I've been very pleased with the results I've achieved by switching from the regular carbidopa-levodopa that I've used for years to the older extended release pill.
My pharmacist tells me that my insurance company hasn't approved rytary yet and that it cost $900. I'm sure I'll get the approval but will the new pill prove to be that much better than what I'm taking now?
I discussed all of this in two posts on my blog last week -- bit.ly/1ImvQKo and bit.ly/1fnKfyS
Note: I'm providing these links, not in an attempt to generate traffic for my blog, but rather because my age (86) and my Parkinson's prompt me to use any shortcuts I can.